Literature DB >> 24973500

Age related differences in diaphragm muscle fiber response to mid/long term controlled mechanical ventilation.

Nicola Cacciani1, Hannah Ogilvie2, Lars Larsson3.   

Abstract

BACKGROUND: Critically ill intensive care patients are subjected to controlled mechanical ventilation (CMV) which has an important association in triggering the impaired muscle function and the consequent delayed weaning from the respirator. AIM: The main aim of this study was to measure the effects of age and CMV over a period up to 5days on rat diaphragm muscle fibers, more specifically focusing on the changes in fiber structure and function.
METHODS: Diaphragm muscle fiber cross-sectional area (CSA) and force generating capacity were measured in young (6months) and old (28-32months) rats in response to five days of CMV. To investigate the biological age of the old rats in this rat strain (F344 BN hybrid), a second set of experiments comparing muscle fiber size and specific force (maximum force normalized to CSA) was investigated in fast- and slow-twitch distal hind limb muscles in 3 different age groups: young adults (6months), middle aged (18months) and old rats (28months).
RESULTS: This study shows an unexpected response of the diaphragm fibers to 5days CMV, demonstrating an increased CSA (p<0.001) in both young and old animals. Furthermore, an observed decreased maximum force of 39.8-45.2% (p<0.001) in both young and old animals compared with controls resulted in a dramatic loss of specific force. We suggest that this increase in CSA and decrease in specific force observed in both the young and old diaphragm fibers is an ineffective compensatory hypertrophy in response to the CMV. These results demonstrate an important mechanism of significant importance for the weaning problems associated with mechanical ventilation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age; Contractile dysfunction; Diaphragm

Mesh:

Year:  2014        PMID: 24973500     DOI: 10.1016/j.exger.2014.06.017

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  7 in total

1.  Advanced aging causes diaphragm functional abnormalities, global proteome remodeling, and loss of mitochondrial cysteine redox flexibility in mice.

Authors:  Rachel C Kelley; Brian McDonagh; Leonardo F Ferreira
Journal:  Exp Gerontol       Date:  2017-12-28       Impact factor: 4.032

2.  A Proteomic Approach to Identify Alterations in the Small Ubiquitin-like Modifier (SUMO) Network during Controlled Mechanical Ventilation in Rat Diaphragm Muscle.

Authors:  Arvind Venkat Namuduri; Gabriel Heras; Jia Mi; Nicola Cacciani; Katarina Hörnaeus; Anne Konzer; Sara Bergström Lind; Lars Larsson; Stefano Gastaldello
Journal:  Mol Cell Proteomics       Date:  2017-04-03       Impact factor: 5.911

Review 3.  Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology.

Authors:  Rachel C Kelley; Leonardo F Ferreira
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

4.  The effects of buthionine sulfoximine treatment on diaphragm contractility and SERCA pump function in adult and middle aged rats.

Authors:  Ian C Smith; Chris Vigna; Andrew S Levy; Steven G Denniss; James W E Rush; A Russell Tupling
Journal:  Physiol Rep       Date:  2015-09

5.  Targeting Heat Shock Proteins Mitigates Ventilator Induced Diaphragm Muscle Dysfunction in an Age-Dependent Manner.

Authors:  Hannah Ogilvie; Nicola Cacciani; Hazem Akkad; Lars Larsson
Journal:  Front Physiol       Date:  2016-09-27       Impact factor: 4.566

Review 6.  Ultrasound and non-ultrasound imaging techniques in the assessment of diaphragmatic dysfunction.

Authors:  Franco A Laghi; Marina Saad; Hameeda Shaikh
Journal:  BMC Pulm Med       Date:  2021-03-15       Impact factor: 3.317

7.  Reply from Lars Larsson, Nicola Cacciani and Barry Dworkin.

Authors:  Lars Larsson; Nicola Cacciani; Barry Dworkin
Journal:  J Physiol       Date:  2015-08-01       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.